Laboratory Corporation of America Holdings (0JSY.L)
0JSY.L Stock Price Chart
Explore Laboratory Corporation of America Holdings interactive price chart. Choose custom timeframes to analyze 0JSY.L price movements and trends.
0JSY.L Company Profile
Discover essential business fundamentals and corporate details for Laboratory Corporation of America Holdings (0JSY.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Jan 2018
Employees
60.90K
Website
https://www.labcorp.comCEO
Adam H. Schechter
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
0JSY.L Financial Timeline
Browse a chronological timeline of Laboratory Corporation of America Holdings corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 22 Oct 2025
Upcoming earnings on 24 Jul 2025
Revenue estimate is $3.49B.
Dividend declared on 29 May 2025
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 11 Jun 2025.
Earnings released on 29 Apr 2025
EPS came in at $2.52 falling short of the estimated $3.74 by -32.62%, while revenue for the quarter reached $3.35B, missing expectations by -3.84%.
Dividend declared on 27 Feb 2025
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 12 Mar 2025.
Earnings released on 6 Feb 2025
EPS came in at $1.70 falling short of the estimated $3.39 by -49.85%, while revenue for the quarter reached $3.33B, missing expectations by -2.42%.
Dividend declared on 26 Nov 2024
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 13 Dec 2024.
Earnings released on 24 Oct 2024
EPS came in at $2.01 falling short of the estimated $3.47 by -42.07%, while revenue for the quarter reached $3.28B, missing expectations by -0.76%.
Dividend declared on 29 Aug 2024
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 13 Sept 2024.
Earnings released on 1 Aug 2024
EPS came in at $2.44 falling short of the estimated $3.78 by -35.45%, while revenue for the quarter reached $3.22B, beating expectations by +1.11%.
Dividend declared on 24 May 2024
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 12 Jun 2024.
Earnings released on 25 Apr 2024
EPS came in at $2.69 falling short of the estimated $3.48 by -22.70%, while revenue for the quarter reached $3.18B, beating expectations by +1.88%.
Dividend declared on 26 Feb 2024
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 13 Mar 2024.
Earnings released on 15 Feb 2024
EPS came in at -$1.97 falling short of the estimated $3.26 by -160.37%, while revenue for the quarter reached $3.03B, beating expectations by +0.51%.
Dividend declared on 7 Nov 2023
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 12 Dec 2023.
Earnings released on 26 Oct 2023
EPS came in at $2.11 falling short of the estimated $3.33 by -36.64%, while revenue for the quarter reached $3.06B, beating expectations by +2.17%.
Dividend declared on 7 Aug 2023
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 8 Sept 2023.
Earnings released on 27 Jul 2023
EPS came in at $2.12 falling short of the estimated $3.84 by -44.79%, while revenue for the quarter reached $3.03B, missing expectations by -19.47%.
Dividend declared on 17 May 2023
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 8 Jun 2023.
Earnings released on 25 Apr 2023
EPS came in at $2.39 falling short of the estimated $3.40 by -29.71%, while revenue for the quarter reached $3.78B, beating expectations by +2.32%.
Dividend declared on 22 Feb 2023
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 13 Mar 2023.
Earnings released on 16 Feb 2023
EPS came in at $0.86 falling short of the estimated $3.53 by -75.78%, while revenue for the quarter reached $3.67B, missing expectations by -1.79%.
Dividend declared on 16 Nov 2022
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 9 Dec 2022.
Earnings released on 30 Sept 2022
EPS came in at $3.89 falling short of the estimated $4.01 by -2.99%, while revenue for the quarter reached $3.61B, missing expectations by -4.76%.
Dividend declared on 17 Aug 2022
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 9 Sept 2022.
Earnings released on 30 Jun 2022
EPS came in at $3.87 falling short of the estimated $4.04 by -4.21%, while revenue for the quarter reached $3.70B, missing expectations by -1.47%.
Dividend declared on 18 May 2022
A dividend of $0.72 per share was announced, adjusted to $0.72. The dividend was paid on 9 Jun 2022.
Earnings released on 31 Mar 2022
EPS came in at $5.23 surpassing the estimated $5.13 by +1.95%, while revenue for the quarter reached $3.90B, missing expectations by -2.65%.
Earnings released on 10 Feb 2022
EPS came in at $5.75 surpassing the estimated $5.13 by +12.09%, while revenue for the quarter reached $4.06B, beating expectations by +3.55%.
Earnings released on 28 Oct 2021
EPS came in at $4.76, while revenue for the quarter reached $3.84B.
Earnings released on 30 Sept 2021
EPS came in at $6.05, while revenue for the quarter reached $4.06B.
Earnings released on 31 Mar 2021
EPS came in at $7.81, while revenue for the quarter reached $4.16B.
Earnings released on 31 Dec 2020
EPS came in at $9.55, while revenue for the quarter reached $4.49B.
Earnings released on 30 Sept 2020
EPS came in at $7.17, while revenue for the quarter reached $3.90B.
0JSY.L Stock Performance
Access detailed 0JSY.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.